Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing.
Gene silencing mediated by small interfering RNA (siRNA) is a novel approach in the development of new cancer therapeutics. Polycations used for nucleic acid delivery still remain heterogeneous compounds, despite continuous progress in polymer synthetic technologies. Here we report the development of a structural defined folic acid polyethylene glycol (PEG) siRNA conjugate accessible via click chemistry yielding a monodisperse ligand-PEG-siRNA conjugate. The folic acid targeting ligand was synthesized by solid phase supported peptide chemistry. The conjugate was shown to be specifically internalized into folic acid receptor expressing cells. When combined with a structurally defined polycation, again synthesized with the precision of solid phase chemistry, efficient receptor specific gene silencing is achieved.
Pharmaceutical Biotechnology, Center of System-based Drug Research, Center for Nanoscience, Ludwig-Maximilians-University, Munich, Germany.
Christian
C
Dohmen
Thomas
T
Fröhlich
Ulrich
U
Lächelt
Ingo
I
Röhl
Hans-Peter
HP
Vornlocher
Philipp
P
Hadwiger
Ernst
E
Wagner